Retained cocaine conditioned place preference in D1 receptor deficient mice

被引:98
作者
Miner, LL
Drago, J
Chamberlain, PM
Donovan, D
Uhl, GR
机构
[1] MONASH UNIV,DEPT ANAT,CLAYTON,VIC 3168,AUSTRALIA
[2] JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROL,BALTIMORE,MD 21224
[3] JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21224
关键词
cocaine; conditioned place preference; D1 dopamine receptor; homologous recombination;
D O I
10.1097/00001756-199511270-00011
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
THE role of the D1 dopamine receptor subtype in mediating cocaine effects was examined in mice in which the D1 receptor gene had been ablated by homologous recombination. Cocaine reward was assessed by conditioned place preference experiments using mice which had either one allele (+/-) or both alleles (-/-) of the D1 dopamine receptor gene disrupted and in their wild type (+/+) littermates. Cocaine conditioning resulted in similar increases in preference for drug-paired environments in mice of each of the three genotypes. Cocaine did not alter locomotor activity levels in homozygous, D1 knockout mice -/-, whereas increased activity was noted in both +/+ and +/- animals. These results are consistent with the idea that the D1 receptor is involved in the locomotor stimulant effects of cocaine, but has little role in a major test of the rewarding and reinforcing effects of the drug.
引用
收藏
页码:2314 / 2316
页数:3
相关论文
共 13 条
[1]  
Robbins T.W., Everitt B.J., Semin Neurosci, 4, pp. 119-127, (1992)
[2]  
Robbins T.W., Cador M., Taylor J.R., Neurosci Biobehav Rev, 13, pp. 155-162, (1989)
[3]  
Wise R.A., Bozarth M.A., Psychol Rev, 94, pp. 469-492, (1987)
[4]  
Gingrich J.A., Caron M.G., Annu Rev Neurosci, 16, pp. 299-321, (1993)
[5]  
Telia S.R., Pharmacol Biochem Behav, 48, pp. 151-159, (1994)
[6]  
Spealman R.D., Bergman J., Madras B.K., J Pharmacol Exp Ther, 258, pp. 945-953, (1991)
[7]  
Caine S.B., Koob G.F., J Pharmacol Exp Ther, 270, pp. 209-218, (1994)
[8]  
Drago J., Gerfen C.F., Lachowicz J.E., Proc Natl Acad Sci USA, 91, pp. 12564-12568, (1994)
[9]  
Xu M., Moratella R., Gold L.H., Cell, 79, pp. 729-742, (1994)
[10]  
Risinger F.O., Malott D.H., Prather L.K., Psychopharmacology, 116, pp. 207-216, (1994)